NCT03570203View on ClinicalTrials.gov

Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors

CompletedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

December 15, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Supratentorial Brain Tumor
Interventions
DIAGNOSTIC_TEST

Serum Sodium

Measurement of serum sodium.

All Listed Sponsors
lead

National Institute of Mental Health and Neuro Sciences, India

OTHER

NCT03570203 - Spectrum of Serum Sodium Disturbances in Patients With Non-sellar/Suprasellar Supratentorial Tumors | Biotech Hunter | Biotech Hunter